Skip to main content
S

SCL Science Inc. — Investor Relations & Filings

Ticker · 246960 ISIN · KR7246960009 KO Professional, scientific and technical activities
Open in API
Filings indexed 310 across all filing types
Latest filing 2021-04-14 Major Shareholding Noti…
Country KR South Korea
Listing KO 246960

About SCL Science Inc.

https://sclscience.com/en

SCL Science Inc., formerly InnoTherapy Inc., is a healthcare company focused on digital innovation and advanced medical technologies. The company develops and commercializes medical hemostatic agents based on its proprietary biomimetic technology, including the Bio-inspired Medical Materials (BiMM) product line. Leveraging 40 years of expertise in medical science, SCL Science is also dedicated to building a digital healthcare ecosystem using artificial intelligence and high-quality medical data. Its services extend to clinical trial analysis, bio-logistics, and an expanding drug discovery platform focused on AI-driven cancer vaccine development. The company serves hospitals, research laboratories, and other medical institutions.

Recent filings

Filing Released Lang Actions
주식등의대량보유상황보고서(약식)
Major Shareholding Notification Classification · 1% confidence The document is a 'Report on Large Shareholding' (주식등의 대량보유상황보고서) filed with the Financial Supervisory Service (FSS) in South Korea. This type of filing is required when an entity acquires 5% or more of a company's shares or experiences significant changes in their holdings. In the provided taxonomy, this corresponds to a 'Major Shareholding Notification' (MRQ).
2021-04-14 Korean
증권발행결과(자율공시)(제2회차 CB)
Share Issue/Capital Change Classification · 1% confidence The document is a formal announcement regarding the results of a securities issuance (specifically a convertible bond, '제2회 무기명식 무보증 사모 전환사채'). It details the issuance amount, payment date, and method. This falls under the category of capital and financing updates, specifically related to the issuance of debt instruments.
2021-04-09 Korean
증권발행결과(자율공시)(전환우선주)
Share Issue/Capital Change Classification · 1% confidence The document is a 'Securities Issuance Result' (증권 발행결과) announcement regarding a third-party paid-in capital increase (제3자배정 유상증자) for convertible preferred shares. It details the number of shares issued, the total amount, and the payment date. This falls under the category of share issuance and capital changes.
2021-04-09 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 1% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea under the Capital Markets Act. It details changes in share ownership by major shareholders and special related parties (directors/executives). This type of filing is specifically categorized as a 'Major Shareholding Notification' (MRQ) in the provided schema.
2021-04-02 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 1% confidence The document is a 'Report on Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서) filed with the Korean financial authorities (Financial Supervisory Service/Korea Exchange). This type of filing is specifically used for reporting insider transactions (purchases or sales of shares by directors or major shareholders). According to the provided definitions, 'Director's Dealing' (DIRS) is the correct category for reports of personal share transactions by company directors and executives.
2021-04-02 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 1% confidence The document is a regulatory filing titled '임원ㆍ주요주주 특정증권등 소유상황보고서' (Report on Ownership of Specific Securities by Executives and Major Shareholders). It details the change in share ownership by an executive (Lee Hae-Shin) of InnoTherapy due to their resignation. This type of filing is a standard disclosure for insider trading or changes in executive holdings, which falls under the 'Director's Dealing' category.
2021-04-02 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.